Why Colgate Palmolive (COLPAL) Share Price is Falling Today | 29 September 2026

NSE: COLPAL · 29 September 2026 · Dated market coverage

Price
₹1,785.10
Change
-3.29%
High / Low
₹1,833.20 / ₹1,785.10
Prev. Close
₹1,845.90
Volume
256,830
Price as of
29 Sep 2026 • 03:15 PM IST
Key Takeaways
  • The stock is -3.29% at ₹1,785.10.
  • Likely reason:Selling pressure near 52-week lows amid weak volume
  • Approximate traded value is₹45.85 crore.
  • It is -23.38% from its 52-week high and +0.17% from its 52-week low.
  • The stock is being compared withNifty FMCGalongside the Nifty 50.

Why Is Colgate Palmolive Share Price Falling Today?

Latest NSE EOD report: 2026-09-29. Today’s Volume: 256,830; 5-Day Avg. Volume: 338,945; 20-Day Avg. Volume: 418,760; Volume vs 20-Day Avg.: 0.61x; Delivery Quantity: 162,033; Delivery %: 61.74%; Number of Trades: 22,457.

Colgate Palmolive Ltd (COLPAL) fell sharply today, shedding 3.29% to close at ₹1,785.10 after touching an intraday low of ₹1,782.00, which matches its 52-week low level. The stock opened lower at ₹1,833.20 and stayed near the bottom of its daily range throughout the session, accompanied by a muted volume of roughly 2.57 lakh shares, which is below its 5-day and 20-day averages.

The broader market and sector backdrop remained subdued, with the Nifty index slipping 0.28%. COLPAL’s ongoing downward trajectory—showing a 5-day return of -4.49% and a 20-day return of -4.02%—reflects continued selling pressure and weak buying interest in the counter relative to broader equities.

While there are no same-day operational triggers accounting for the drop, the company recently announced key leadership transitions, including the appointment of Manish Anandani as Managing Director & CEO effective late September 2026, alongside corporate updates such as new product milestones for Colgate PerioGard. These developments serve as structural context for ongoing management shifts rather than immediate catalysts for today’s price action.

Likely Reason for Today’s Move

low confidence

Selling pressure near 52-week lows amid weak volume
The stock declined towards its 52-week low of ₹1,782 with below-average trading volumes and no direct negative catalyst announced today. The move appears driven by persistent technical weakness and profit-taking or lack of institutional buying following recent underperformance.
  • Stock touched a day low of ₹1,785.10, matching the 52-week low of ₹1,782.00
  • Volume was lower than usual at 76% of its 5-day average
  • No major corporate announcements or negative earnings surprises reported today

Latest Company Developments

Appointment of New Managing Director & CEO
28-Sep-2026
The company completed the transition of its top leadership, with Manish Anandani formally taking charge as the Managing Director & CEO starting September 28, 2026. He succeeds Prabha Narasimhan, whose cessation as MD & CEO became effective a day prior on September 27, 2026. This high-level executive change marks a new phase for the personal care major’s strategic execution in India.
Why it matters:Leadership continuity and execution under a new CEO are critical for maintaining the company’s market share in the competitive oral care segment.

Legal Leadership Resignation and Appointment
28-Sep-2026
Colgate Palmolive announced that Priyan Pillay will step down as the Executive Vice-President – Legal, effective October 23, 2026. Concurrently, the company appointed Abhijit Yadav to succeed him in the same role, effective October 24, 2026. These disclosures were submitted to the exchange under regulatory compliance norms.
Why it matters:Smooth transitions in key managerial positions ensure ongoing legal and regulatory compliance without disrupting daily operations.

Colgate PerioGard Earns ISP Seal of Acceptance
18-Aug-2026
The company announced that its Colgate PerioGard product range became India’s first gum care regimen to earn the ISP Seal of Acceptance. This recognition highlights the brand’s scientific backing and focus on targeted therapeutic oral care solutions. The development reinforces product differentiation in the premium healthcare segment.
Why it matters:Accreditations for specialized product lines help drive brand equity and support pricing power in urban and professional recommendations.

What Should Traders and Investors Watch Next?

  • Price stability around the 52-week low support level near ₹1,782
  • Delivery percentage trends (currently around 61.74%) to track institutional accumulation
  • Execution of strategy and commentary under newly appointed MD & CEO Manish Anandani
  • Upcoming quarterly financial results and margin trajectory given past pressures from higher ad-spends

Catalyst note:No single confirmed news catalyst was identified for today’s price decline, which reflects ongoing technical weakness near 52-week lows.

Frequently Asked Questions

What is the likely reason for today’s move?

The stock declined towards its 52-week low of ₹1,782 with below-average trading volumes and no direct negative catalyst announced today. The move appears driven by persistent technical weakness and profit-taking or lack of institutional buying following recent underperformance.

Is trading volume elevated?

Today’s volume is 256,830. The latest 20-day average available is 418,760, equivalent to about 0.61x of the recent average.

Before acting on this stock

Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review theWittyTrades subscription plans and research segments.

Article by:WittyTrades Research Desk

Disclaimer:Investments in securities markets are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors. This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security. Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions.

Other Dated Coverage

More Colgate Palmolive news and dated analysis →

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top